MONTREAL, Aug. 26, 2014 When it comes to diabetes supplies, innovations are often accused of having very little clinical relevance. But Timesulin happens to answer a real medical need.
Fitting most of insulin disposable pen on the market, Timesulin shows how long it's been since your last injection. One advantage being, indeed, preventing from missed or double insulin doses. Very easy to use, Timesulin starts automatically once it is put back on the insulin pen after an injection. There is no settings or complicated handling needed. Therefore, it enhances safety and eases daily worries for diabetic patients.
According the 2010 Novo Nordisk Gapp study (conducted among almost 3,000 physicians and patients in 8 countries), more than four in 10 people with diabetes say they struggle to effectively control their blood sugar either it is because they forget a dose, fail to take their insulin treatment properly or double their dose. Also, 67% of patients taking insulin are concerned about experiencing a hypoglycemic event in the future.
From a public health perspective, the disease and its treatments can lead to a variety of short-term and long-term complications such as infections, slow wound healing, cardiovascular disease, vision loss, kidney failure, nerve damage, problems with pregnancy, oral disease and so on. Those health issues, as well as diabetes management itself, result in reduced quality of life, work limitations and higher risk of early death. They also greatly increase the need for health care resources and the economic burden of diabetes for society.
Widely used, Timesulin cap could help avoid hypo or hyperglycemic episodes and related complications and reduce future diabetes-related expenditures.
By securing reimbursement for Timesulin, Montméd and insurance companies have shown their understanding of the complexity of care in diabetes and their commitment to diversify the
Copyright©2014 PR Newswire.
All rights reserved